[1]
D. M. Upadhyay, M. Ahmad, M. Misra, S. Chawdhary, and S. C. Maurya, “Comparison of saftey and cost effectiveness of atorvastatin 40 mg daily, rosuvastatin 20 mg daily and rosuvastatin 20 mg alternate day in 300 patients with type 2 diabetes mellitus”, Int J Res Med Sci, vol. 5, no. 5, pp. 2069–2075, Apr. 2017.